Cell MedX Corp (CMXC)
0.034
-0.01
(-20.93%)
USD |
OTCM |
Jun 25, 12:37
Cell MedX Net Income (Quarterly): 0.12M for Feb. 29, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.12M |
| November 30, 2023 | -0.0605M |
| August 31, 2023 | -0.077M |
| May 31, 2023 | -0.0794M |
| February 28, 2023 | -0.1182M |
| November 30, 2022 | -0.1428M |
| August 31, 2022 | -0.1547M |
| May 31, 2022 | -0.1626M |
| February 28, 2022 | -0.1195M |
| November 30, 2021 | -0.176M |
| August 31, 2021 | -0.2394M |
| May 31, 2021 | -0.3413M |
| February 28, 2021 | -0.179M |
| November 30, 2020 | -0.1893M |
| August 31, 2020 | -0.2012M |
| May 31, 2020 | -0.183M |
| February 29, 2020 | -0.3609M |
| November 30, 2019 | -0.3035M |
| August 31, 2019 | -0.2453M |
| May 31, 2019 | -0.1443M |
| February 28, 2019 | -0.3907M |
| November 30, 2018 | -0.1275M |
| August 31, 2018 | -0.2435M |
| May 31, 2018 | -0.2363M |
| February 28, 2018 | -0.2958M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.1814M |
| August 31, 2017 | -0.8333M |
| May 31, 2017 | 0.3941M |
| February 28, 2017 | -0.3046M |
| November 30, 2016 | -1.060M |
| August 31, 2016 | -0.2788M |
| May 31, 2016 | -0.3341M |
| February 29, 2016 | -0.296M |
| November 30, 2015 | -0.4796M |
| August 31, 2015 | -1.029M |
| May 31, 2015 | -0.2924M |
| February 28, 2015 | -0.4192M |
| November 30, 2014 | -0.2727M |
| August 31, 2014 | -0.0479M |
| May 31, 2014 | -0.0054M |
| February 28, 2014 | -0.0044M |
| November 30, 2013 | -0.0028M |
| August 31, 2013 | -0.0059M |
| May 31, 2013 | -0.0015M |
| February 28, 2013 | -0.0063M |
| November 30, 2012 | -0.0048M |
| August 31, 2012 | |
| May 31, 2012 | -0.0023M |
| February 29, 2012 | -0.0041M |
| November 30, 2011 | -0.0059M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-0.3609M
Minimum
Feb 2020
0.12M
Maximum
Feb 2024
-0.1691M
Average
-0.176M
Median
Nov 2021
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -12.28M |
| Electromed Inc | 1.493M |
| Xtant Medical Holdings Inc | -4.40M |
| Asensus Surgical Inc | -22.50M |
| Senseonics Holdings Inc | -18.88M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.0578M |
| EPS Diluted (Quarterly) | 0.0005 |
| Enterprise Value | 10.35M |
| Earnings Yield | -4.83% |
| Normalized Earnings Yield | -19.43 |